ArticleBiophysical journal2026
Glycosylation-modulated conformational diversity in neurotrophin receptors.
Article in Biophysical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glycosylation is a widespread modification of cell-surface receptors, yet its structural impact is often overlooked due to the difficulty of experimentally characterizing glycans. Glycosylation of neurotrophin receptors has been reported to affect their localization and function. To investigate the effects of glycosylation of the extracellular domains (ECDs) of p75, TrkA, and TrkB neurotrophin receptors, we modeled their ECDs in glycosylated and non-glycosylated states and carried out molecular dynamics simulations of monomeric and dimeric forms of the ECDs with and without a neurotrophin bound. The single N-glycan on the p75 ECD provided minimal shielding and had limited interaction with the neurotrophin, although glycan-glycan contacts between the two p75 monomers may influence the stability of the receptor-neurotrophin complex. In contrast, TrkA and TrkB carry multiple N-glycans that shield the ECDs much more and, particularly for TrkB, increase the contact area between the receptor and the neurotrophin. The p75 ECD was comparatively rigid, independent of glycosylation state, likely due to its extensive network of disulfide bonds. In contrast, without glycans, the TrkA- and TrkB-ECDs tended to collapse inward, sometimes obstructing the neurotrophin binding site. Glycosylation of TrkA and TrkB prevented bending of the ECD into more compact states and instead promoted extended conformations that better accommodate neurotrophin binding. Overall, the simulations reveal distinct, receptor-specific roles of glycosylation in modulating neurotrophin receptor shielding, flexibility, and conformation with effects on neurotrophin binding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.